GlassScriptPhysician profile
Nicole J Schultz
NPI 1194470518
$1,360.59
in general payments reported to CMS, 2019-2025
17 companies · $761 in 2025
The $761 reported for 2025 was more than what 79% of Physician Assistant providers received nationally (typical 2025 total: $183).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $29.80 · 2023: $77.43 · 2024: $493 · 2025: $761.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,274 · Education: $56.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,273.80 |
| Education | $56.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Regeneron Healthcare Solutions, INC. | $296.00 | 2024-2025 | Dupixent |
| Genzyme Corporation | $235.58 | 2024-2025 | |
| Glaxosmithkline, LLC. | $206.89 | 2024-2025 | Nucala |
| Optinose US, INC. | $175.71 | 2024-2025 | |
| Abbvie INC. | $159.87 | 2022-2025 | |
| Sanofi-Aventis U.S. LLC | $56.99 | 2025 | |
| Astellas Pharma US INC | $54.11 | 2023-2024 | Veozah |
| Merck Sharp & Dohme LLC | $33.57 | 2023-2024 | Gardasil 9, Vaxelis, Varivax |
| Tactile Systems Technology INC | $24.30 | 2024 | Entre Plus, Flexitouch Plus |
| Idorsia Pharmaceuticals US INC | $16.61 | 2023 | Quviviq |
| Lilly USA, LLC | $15.47 | 2024 | Jardiance |
| Medline Industries LP | $15.46 | 2024 | Medline Industries, INC. |
| Janssen Pharmaceuticals, INC | $15.36 | 2022 | |
| Almatica Pharma LLC | $14.59 | 2024 | Teriparatide |
| Paratek Pharmaceuticals, INC. | $13.74 | 2025 | Xhance |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Phadia US INC. | $13.51 | 2025 | Immunocap |
| Amgen INC. | $12.83 | 2023 | Evenity, Prolia |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Nicole Schultz listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.